Drugs / Technetium[99mTc] Methylenediphosphonate
Technetium[99mTc] Methylenediphosphonate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05614518 Comparator | Mar 2021 → Jun 2022 | musculoskeletal system cancer | HTA Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Technetium[99mTc] Methylenediphosphonate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05614518 ↗ |
| Modality | Diagnostic / imaging agent | “99mTc-MDP-BS±SPECT bone imaging” NCT05614518 ↗ |
| Route | Intravenous | “Administer 10-25 mCi as an intravenous injection” NCT05614518 ↗ |